Updated HIV Drug Guidelines Available on the Internet

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 6
Volume 8
Issue 6

BETHESDA, Md-The newest version of “Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents” is now available on the Internet at www.hivatis.org. The update includes recommendations about the use of Ziagen (abacavir), which can be given in combination with Retrovir (zidovudine) and Epivir (lamivudine). All three drugs are nucleoside analog reverse transcriptase inhibitors.

BETHESDA, Md—The newest version of “Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents” is now available on the Internet at www.hivatis.org. The update includes recommendations about the use of Ziagen (abacavir), which can be given in combination with Retrovir (zidovudine) and Epivir (lamivudine). All three drugs are nucleoside analog reverse transcriptase inhibitors.

However, the panel that created the guidelines is concerned about the ability of this three-drug regimen “to adequately suppress HIV replication in individuals with high baseline levels of plasma viral load,” said co-chair John G. Bartlett, MD, of Johns Hopkins Medical Center. Thus, it recommends the Ziagen-Retrovir-Epivir combination be considered an “alternative” to other regimens described in the guidelines.

The guidelines are a joint effort by the US Department of Health and Human Services and the Henry J. Kaiser Family Foundation.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.